Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits

Yinjie Zhu(Shanghai Jiao Tong University), Wei Xue(National Sun Yat-sen University), Liancheng Fan(Shanghai Jiao Tong University), Jiahua Pan(University of Science and Technology of China), Hanjing Zhu(Shanghai Jiao Tong University), Yiming Gong(Chongqing University), Baijun Dong(Shanghai Jiao Tong University), Yanqing Wang(First Affiliated Hospital of Xiamen University), Chenfei Chi(Shanghai Jiao Tong University)
Frontiers in Oncology
May 17, 2023
Cited by 1


Related Papers